LAKEWOOD, Colo.--(BUSINESS WIRE)--ZeaChem Inc., a developer of biorefineries for the conversion of renewable biomass into sustainable fuels and chemicals, has added Nancy Buese as the third independent board member and audit chair on its Board of Directors.
Buese brings 20 years of financial leadership to the ZeaChem Board. She currently serves as senior vice president and chief financial officer of Denver-based MarkWest Energy Partners L.P. (NYSE: MWE), a leading provider of midstream services in the natural gas industry. Previously she was the chief financial officer for Experimental and Applied Sciences (EAS) in Golden, Colo., and a vice president with TransMontaigne Inc. in Denver. Prior to these appointments she was a partner at Ernst & Young LLP, and worked in the firm’s Denver, London, New York and Washington, D.C., offices.
“We are pleased to welcome Nancy Buese to ZeaChem’s Board of Directors. She brings a deep background in finance and valuable fuels sector expertise to advise the ZeaChem team as we move toward commercialization,” said Jim Imbler, president and chief executive officer of ZeaChem.
Buese’s appointment follows the October 2011 addition of Birchmere Ventures Partner Sean D.S. Sebastian, as well as independent board members Ross Pillari and Charles “Charlie” Shaver, to the ZeaChem Board of Directors.
About ZeaChem Inc.
ZeaChem Inc. has developed a cellulose-based biorefinery platform capable of producing advanced fuels and intermediate chemicals. ZeaChem's indirect approach leapfrogs the yield and carbon dioxide (CO2) problems associated with traditional and cellulosic based biorefinery processes. In addition, ZeaChem has a significant capital cost advantage compared to other cellulosic technologies. By efficiently extracting the most energy possible from biomass feedstocks, ZeaChem significantly increases output while reducing both production costs and environmental impacts. Incorporated in 2002, ZeaChem is headquartered in Lakewood, Colo. and operates a research and development laboratory facility in Menlo Park, Calif.
Please visit www.zeachem.com for more information.